Digestive Enzymes Supplements Market by Sources (Animal, Plant, Microbial, and Others) and Applications (Additional Supplements, Medical and Infant Nutrition, and Sports Nutrition)—Market Growth, Future Prospects, and Competitive Analysis, 2017–2025
The human body is known to produce 22 different types of enzymes; however, a shortage of digestive enzymes may occur in the human body. Lactase deficiency is the best-known example, which affects 70% of the world’s population. Aging also has an impact on the body’s ability to produce digestive enzymes, resulting in a 50% loss of digestive activity. Digestive enzymes are beneficial in easing the stress on the stomach, gallbladder, liver, small intestine, and pancreas to digest starch, fats, and proteins.
For the purpose of this study, the various sources studied include animal, plant, microbial, and others. The applications are classified as additional supplements, medical and infant nutrition, and sports nutrition. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.The digestive enzymes supplements market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global digestive enzyme supplements market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment, and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global digestive enzyme supplements market. The key players profiled in this report are Amway, Douglas Labs, Herbalife, Integrative Therapeutics, Klaire Labs, Lonza Group Ltd., Metagenics, National Enzymes Company, Nestec SA, Nutricia NV, ProteoZymes, and other notable players.
Based on the source, the global digestive enzyme supplements market is categorized into
Factors such as rising public awareness about maintaining a healthy lifestyle increased consumption of junk food items leading to gastrointestinal disturbances, and a stress-inducing hectic lifestyle is driving the digestive enzymes supplements market. In addition, the technological revolution in the dietary supplement industry over the past decade, with excellent results and patient compliance, will propel deep market penetration for digestive enzyme supplements.
In 2016, animal sources held the largest market share, chiefly due to factors such as technological advancement in the formulation of pancreatic enzymes such as pancreatin, trypsin, and chymotrypsin, which are active at high pH levels but are now enteric coated, so they are functional in the alkaline pH of the small intestine. However, due to reported sensitivity and allergies to animal-derived enzymes, they are likely to face restrictions. Plant sources will be the fastest-growing segment throughout the forecast period of 2017–2025 as they find huge applications in reducing acid indigestion, heartburn, reflux, and other digestive disturbances.
In addition, the plant-derived enzymes are functional over a much broader pH range. Microbial enzymes will have an excellent growth trend throughout the forecast period as fermented microbes exhibit broad pH activity and substrate specificity. The major players in the digestive enzyme supplements market are Amway, Douglas Labs, Herbalife, Integrative Therapeutics, Klaire Labs, Lonza Group Ltd., Metagenics, National Enzymes Company, Nestec SA, Nutricia NV, ProteoZymes, and other notable players.
Based on application, the digestive enzyme supplements market is categorized into
- Additional Supplements
- Medical and Infant Nutrition
- Sports Nutrition
Digestive issues arise from a number of factors, such as decreased food intake, malabsorption, diarrhea, and bacterial overgrowth. An increasing number of patients suffering from obesity and gastroesophageal disease and rising consumer preference for over-the-counter digestive supplements will boost market penetration for digestive enzyme supplements. In 2016, medical and infant nutrition dominated the market, chiefly due to factors such as the rising prevalence of patients suffering from gastrointestinal complications.
Probiotics are helpful in building the defensive mechanisms of the immune system in infants and maintaining a healthy gut flora to prevent diarrhea, irritable bowel syndrome, and ulcerative colitis in adults. Fiber dietary supplements help to maintain a healthy colon and promote nutrient absorption in the small intestine. Prebiotics has medicinal properties, such as helping to maintain normal blood sugar and cholesterol levels.
However, the stringent regulatory norms regarding prebiotics labeling, which vary region-wise, will hinder the market growth for medical and infant nutrition. The sports nutrition segment is anticipated to register faster growth through the forecast period of 2017–2025, primarily due to increased consumption of these products by athletes, bodybuilders, and patients as a dietary ingredients. Additionally, the rising number of fitness centers and gymnasiums is resulting in growing health consciousness and will propel the demand for sports nutrition supplements.
For the purpose of this study, the global market for digestive enzyme supplements is categorized into the following regional and country-specific markets:
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
In the base year 2016, North America was observed to be the largest regional market for digestive enzyme supplements. According to the Centers for Disease Control and Prevention statistics for 2015, the number of U.S. citizens diagnosed with gastrointestinal ulcers was 14.8 million, which represents 6.1% of the population.
The dominance of North America is mainly attributed to the rising prevalence of patients with gastrointestinal complications, rising public consciousness regarding healthy lifestyles, and the presence of key nutraceutical players focusing on developing digestive enzymes as dietary supplements.
According to the United European Gastroenterology 2016 report, one in every three children in 46 European countries is obese and at risk of developing the gastrointestinal disease. The market growth in Europe is chiefly attributed to factors such as increased consumption of junk food items, increased prevalence of gastrointestinal complications such as GERD, flatulence, inflammatory bowel disease, etc., and supportive regulatory approval for dietary fiber and prebiotic products.
Asia Pacific will be the fastest-growing regional segment throughout the forecast period of 2017–2025. Factors that propel the market’s growth are the presence of a large baby boomer population suffering from digestive disorders and the rising demand for sports nutrition products among athletes, bodybuilders, fitness enthusiasts, etc.
In addition, the rapidly growing nutraceutical dietary supplements industry and large disposable incomes in these regions will propel the dietary enzyme supplements market’s growth. Factors such as developing health infrastructure and government agencies combating malnutrition and hunger in poor nations by providing free food and medical aid are going to fuel the rapid growth of the digestive enzyme supplements market in Latin America, the Middle East, and Africa in the near future.